Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host cell surface polyanions are a diverse group of negatively charged macromolecules, primarily comprising glycosaminoglycans (GAGs) such as heparan sulfate, chondroitin sulfate, and sialic acids, which are covalently attached to proteins on the plasma membrane (Cagno et al., 2019, PubMed). These molecules serve as critical physiological regulators, mediating cell-cell communication, extracellular matrix stability, and the sequestration of various growth factors and cytokines (Kamhi et al., 2013, PubMed). In the context of infectious diseases, many pathogens, including SARS-CoV-2, HIV-1, and Herpes Simplex Virus, exploit these polyanions as initial attachment factors to concentrate on the cell surface before engaging specific entry receptors (Clausen et al., 2020, Cell; Lortat-Jacob, 2009, PubMed). Consequently, they are significant targets for the development of entry inhibitors, which often utilize polyanionic mimics to competitively block pathogen binding (Pirrone et al., 2011, PubMed). Beyond infection, these polyanions play roles in cancer progression by facilitating angiogenesis and tumor cell metastasis, making them targets for enzymatic inhibitors like heparanase antagonists (Vlodavsky et al., 2012, PubMed).
Competitive inhibition of pathogen attachment by mimicking host cell surface charges or enzymatic degradation of polyanionic chains to prevent binding.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host cell surface polyanion (HSPG/GAG).